147 studies found for:    Open Studies | Interleukin
Show Display Options
Rank Status Study
1 Recruiting Interleukin-1 Blockade in HF With Preserved EF
Condition: Heart Failure With Normal Ejection Fraction
Interventions: Drug: Anakinra;   Drug: Placebo
2 Recruiting Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Rilonacept;   Drug: Placebo
3 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
4 Recruiting Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
Condition: Acute Myelogenous Leukemia
Intervention: Drug: Interleukin-2
5 Recruiting Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation
Condition: Immunodeficiency Secondary to Organ Transplantation
Intervention: Procedure: transplantation
6 Recruiting Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity
Conditions: Lipodystrophy;   Obesity;   Type 2 Diabetes
Intervention:
7 Unknown  Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices
Conditions: Diabetes;   Interleukins;   Cytokines
Intervention: Procedure: laparoscopic gastric bypass plus omentectomy
8 Not yet recruiting Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Condition: Autoimmune Hemolytic Anemia
Intervention: Drug: Interleukine-2
9 Not yet recruiting Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo;   Drug: 1.0 MIU IL-2 per day;   Drug: 2.0 MIU IL-2 per day
10 Recruiting Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors
Condition: Neuroblastoma
Intervention: Drug: 3F8 Monoclonal Antibody Combined with Interleukin-2
11 Recruiting Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium
Conditions: Rheumatoid Arthritis;   Periodontitis
Intervention: Other: oral exam and
12 Recruiting Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell Carcinoma
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Fosaprepitant
13 Recruiting Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
Condition: Acute Myeloid Leukemia
Intervention:
14 Not yet recruiting Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma
Condition: Metastatic, Stage III or Stage IV, Melanoma
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Tumor-Infiltrating Lymphocytes;   Biological: Low-Dose Interleukin
15 Recruiting "Re-Stimulated" Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: Recurrent, Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Interventions: Biological: Re-stimulated tumor-infiltrating lymphocytes (TILs);   Biological: Interleukin-2;   Drug: Cyclophosphamide
16 Recruiting Interleukin-1 Blockade in Recently Decompensated Heart Failure
Condition: Heart Failure
Interventions: Drug: Anakinra (weeks 1-2);   Drug: Anakinra (weeks 3-12)
17 Recruiting Interleukin-2 in Metastatic Melanoma
Condition: Melanoma Metastatic
Intervention: Drug: Interleukin-2
18 Recruiting Interleukin-2 in Metastatic Kidney Cancer
Conditions: Renal Cell Cancer Metastatic;   Kidney Cancer Metastatic
Intervention: Drug: Interleukin-2
19 Recruiting Role of Interleukin-6 in Exercise
Conditions: Diabetes Mellitus, Type 2;   Obesity
Interventions: Behavioral: Sport;   Drug: Tocilizumab;   Drug: Sitagliptin
20 Unknown  Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Biological: adenovirus vector;   Biological: interleukin-12 gene

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years